Patients have higher than normal blood pressure which cannot be controlled by multiple drugs. It can cause muscle weakness, ...

A phase III trial of baxdrostat for primary aldosteronism is now underway. Developer AstraZeneca is also testing it as ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.